Faculty

Institution

Unit

Venue

John W. Davis

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Head And Neck Surgery

Division Of Surgery

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Department Of Plastic And Reconstructive Surgery

Section Of Hepato-Pancreato-Biliary

Department Of Surgical Oncology

Division Of Surgery

Department Of Surgical Oncology

Department Of Urology

Department Of Thoracic Surgery

Department Of Neurosurgery

Division Of Surgery

The University of Texas MD Anderson Cancer Center

John W. Davis is a Senior Professor at The University of Texas MD Anderson Cancer Center, specializing in urologic oncology and prostate cancer. His research focuses on optimizing surgical outcomes for localized prostate cancer, including the clinical significance of Grade Group 1 core volume at biopsy, the impact of body mass index on tumor aggression, and the development of automated suturing assessments for radical prostatectomy. He has led phase II trials of neoadjuvant apalutamide for intermediate-risk disease and validated prognostic blood-based sphingolipid panels for men on active surveillance. His work integrates molecular analyses of patient-derived xenografts with translational biomarker research to refine risk stratification and therapeutic decision-making in genitourinary malignancies.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

John W. Davis

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

urology prostate cancer oncology surgical oncology cancer care prostatic disease surgery genitourinary cancers radiation oncology cancer research cancer treatment bladder cancer cancer imaging neurology robot-assisted surgery surgical education tumor biology outcomes research jama oncology active surveillance urogynecology radical prostatectomy cancer discovery cancer management metastasis benign prostatic hyperplasia biomarkers localized prostate cancer surgical pathology laparoscopy pharmacotherapy plastic surgery brachytherapy medicinal research molecular diagnostics oncogenes urological research cancer risk molecular cancer operative treatment cancer genomics clinical radiation oncology computer-assisted surgery palliative medicine cancer cells magnetic resonance imaging radiation therapy medical robots robot-assisted radical prostatectomy cohort studies prognostic biomarkers cancer prevention surgical training abiraterone acetate leuprolide acetate clinical evidence cancer genetics tumor heterogeneity urogenital radiology laparoscopic radical prostatectomy anti-cancer agents therapeutic efficacy treatment effects disease progression treatment options biochemical recurrence hepatocellular carcinoma graft rejection early prostate cancer favourable-risk prostate cancer superficial bladder carcinoma bacillus calmette-guerin salvage radical prostatectomy recurrent prostate cancer future directions decipher test

Notable Scholarly Works

Notable Federal Grants

Collaborators

Does Inclusion of Grade Group 1 Core Volume at Time of Fusion Biopsy Impact Rate of Adverse Pathology at Radical Prostatectomy?. Urologic Oncology Seminars and Original Investigations (2025)

urologysurgical oncologyprostatic diseaseoncologyradiation oncologygenitourinary cancerscancer caresurgical pathologyoutcomes researchprostate cancer

Grade Group 1 Core Volume at Time of Biopsy is Not Associated With Rate of Adverse Pathology at Radical Prostatectomy. JU Open Plus (2025)

urologysurgical oncologyprostatic diseaseoncologyradiation oncologygenitourinary cancersradical prostatectomycore volumecancer caresurgical pathologyprostate cancergrade group 1

A Phase II Trial of Apalutamide for Intermediate‐Risk Prostate Cancer and Molecular Correlates. British Journal of Urology (2024)

Andrew W. HahnGaniraju C. ManyamBrian F. ChapinMiao ZhangYao YuCurtis A. PettawayLisly CheryLouis L. PistersJohn F. WardJustin R. GreggJohn PapadopoulosAshish M. KamatMarisa LozanoAnh HoangBradley BroomXuemei WangChad D. HuffChristopher J. LogothetisPatricia TroncosoPatrick G. PiliéJohn W. Davis

urologyphase ii trialoncologyintermediate-risk prostate cancerpharmacologyprostate cancermolecular correlatesneurologyclinical trials

Capturing Relationships Between Suturing Sub-Skills to Improve Automatic Suturing Assessment. npj Digital Medicine (2024)

Zijun CuiRunzhuo MaCherine H. YangAnand MalpaniTimothy N. ChuAhmed GhaziJohn W. DavisBrian J. MilesClayton LauYan LiuAndrew J. Hung

medicineautomatic suturing assessmentdigital healthdigital medicinehealth sciences

Data From Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-Derived Xenograft (Mda Pca Pdx) Series. (2024)

urologytumor biologycancer genomicsprostatic diseaseintegrative molecular analysesoncologyradiation oncologymolecular cancergenitourinary cancerscancer cellsoncogenesmda pca pdxprostate cancer

Multiparametric Magnetic Resonance Imaging With Targeted-Only Biopsy—a New Standard for Guidelines on Prostate Cancer Detection?. European Urology (2024)

Ppp05 Presentation Time: 11: 06 Am. Brachytherapy (2024)

Osama MohamadAdriana CavazosChad TangHenry MokComron HassanzadehSeungtaek ChoiKaren HoffmanLauren MayoQuynh-Nhu NguyenSean McGuireShalin ShahBrian ChapinJohn DavisPaul CornRajat KudchadkerSurendra PrajapatiTeresa BrunoYusung KimSteven Frank

pain therapysurgical oncologyneurorehabilitationadaptive radiotherapyperformance studiesbrachytherapyradiationsymptomatic treatmentclinical presentationpain medicinebrain tumor researchpain managementrehabilitationtheatre

The Association of Body Mass Index With Tumor Aggression Among Men Undergoing Radical Prostatectomy. Urologic Oncology Seminars and Original Investigations (2024)

Justin R. GreggResa MagillAndrew M. FangBrian F. ChapinJohn W. DavisMehrad AdibiLisly ChéryJohn PapadopoulosCurtis PettawayLouis PistersJohn F. WardAndrew W. HahnCarrie R. DanielJerusha BhaskaranKeyi ZhuMireya GuerreroMiao ZhangPatricia Troncoso

urologysurgerytumor aggressionradical prostatectomyprostate cancerbody mass index

Validation of a Prognostic Blood-Based Sphingolipid Panel for Men With Localized Prostate Cancer Followed on Active Surveillance. Biomarker Research (2024)

Justin R. GreggLisa NewcombRanran WuJennifer DennisonJohn W. DavisCurtis PettawayLouis PistersJohn F. WardBrian F. ChapinLisly ChéryAhmet UrkmezAndrew M. FangNoel HiggasonPatricia TroncosoCarrie R. DanielChristopher LogothetisTimothy C. ThompsonAndrew W. HahnMenghan LiuYingye ZhengDan W. LinSamir HanashEhsan IrajizadJohannes Fahrmann

urologycancer researchactive surveillancebiomarker (medicine)prostate cancerprognostic biomarkerslocalized prostate cancerbiomarkers

A Multi-Institution Study on the Association of Virtual Reality Skills With Continence Recovery After Robot-Assisted Radical Prostatectomy. European Urology Focus (2023)

Timothy N. ChuElyssa Y. WongRunzhuo MaCherine H. YangIstabraq S. DaliehAlvin HuiOscar GomezSteven CenAhmed GhaziBrian J. MilesClayton LauJohn W. DavisMitchell G. GoldenbergAndrew J. Hung

robot-assisted surgeryurologyrobot-assisted radical prostatectomycontinence recoverysurgeryvirtual reality skillsmulti-institution studyvirtual reality

1
2
3
4
5
27
10 / page

John W. Davis

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Head And Neck Surgery

Division Of Surgery

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Department Of Plastic And Reconstructive Surgery

Section Of Hepato-Pancreato-Biliary

Department Of Surgical Oncology

Division Of Surgery

Department Of Surgical Oncology

Department Of Urology

Department Of Thoracic Surgery

Department Of Neurosurgery

Division Of Surgery

The University of Texas MD Anderson Cancer Center

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

John W. Davis

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Does Inclusion of Grade Group 1 Core Volume at Time of Fusion Biopsy Impact Rate of Adverse Pathology at Radical Prostatectomy?. Urologic Oncology Seminars and Original Investigations (2025)

urologysurgical oncologyprostatic diseaseoncologyradiation oncologygenitourinary cancerscancer caresurgical pathologyoutcomes researchprostate cancer

Grade Group 1 Core Volume at Time of Biopsy is Not Associated With Rate of Adverse Pathology at Radical Prostatectomy. JU Open Plus (2025)

urologysurgical oncologyprostatic diseaseoncologyradiation oncologygenitourinary cancersradical prostatectomycore volumecancer caresurgical pathologyprostate cancergrade group 1

A Phase II Trial of Apalutamide for Intermediate‐Risk Prostate Cancer and Molecular Correlates. British Journal of Urology (2024)

urologyphase ii trialoncologyintermediate-risk prostate cancerpharmacologyprostate cancermolecular correlatesneurologyclinical trials

Capturing Relationships Between Suturing Sub-Skills to Improve Automatic Suturing Assessment. npj Digital Medicine (2024)

Zijun CuiRunzhuo MaCherine H. YangAnand MalpaniTimothy N. ChuAhmed GhaziJohn W. DavisBrian J. MilesClayton LauYan LiuAndrew J. Hung

medicineautomatic suturing assessmentdigital healthdigital medicinehealth sciences

Data From Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-Derived Xenograft (Mda Pca Pdx) Series. (2024)

urologytumor biologycancer genomicsprostatic diseaseintegrative molecular analysesoncologyradiation oncologymolecular cancergenitourinary cancerscancer cellsoncogenesmda pca pdxprostate cancer

Multiparametric Magnetic Resonance Imaging With Targeted-Only Biopsy—a New Standard for Guidelines on Prostate Cancer Detection?. European Urology (2024)

Ppp05 Presentation Time: 11: 06 Am. Brachytherapy (2024)

The Association of Body Mass Index With Tumor Aggression Among Men Undergoing Radical Prostatectomy. Urologic Oncology Seminars and Original Investigations (2024)

urologysurgerytumor aggressionradical prostatectomyprostate cancerbody mass index

Validation of a Prognostic Blood-Based Sphingolipid Panel for Men With Localized Prostate Cancer Followed on Active Surveillance. Biomarker Research (2024)

urologycancer researchactive surveillancebiomarker (medicine)prostate cancerprognostic biomarkerslocalized prostate cancerbiomarkers

A Multi-Institution Study on the Association of Virtual Reality Skills With Continence Recovery After Robot-Assisted Radical Prostatectomy. European Urology Focus (2023)

Timothy N. ChuElyssa Y. WongRunzhuo MaCherine H. YangIstabraq S. DaliehAlvin HuiOscar GomezSteven CenAhmed GhaziBrian J. MilesClayton LauJohn W. DavisMitchell G. GoldenbergAndrew J. Hung

robot-assisted surgeryurologyrobot-assisted radical prostatectomycontinence recoverysurgeryvirtual reality skillsmulti-institution studyvirtual reality

1
2
3
4
5
27
10 / page